Regional Monitoring EECA
by ECUO PLWH
Showing 1-8 of 8 items.
Excel
#CountrySource of financingManufacturerTradenameINNFormPrice per unit ($)Units in purchaseUnits in packagePrice per package ($)Packages in purchasePrice per purchase ($)DistributorYearPurchase dateDelivery dateRegisteredIn the list of main (vital) medicationsWHO prequalification
1Republic of PolandGovernmentViiv Healthcare UK LimitedTRIUMEQDolutegravir+Abacavir/Lamivudine50mg+600mg+300mg tab26.112000307834003132002015Not specifiedNot specifiedNot specified
2Republic of PolandGovernmentViiv Healthcare UK LimitedTRIUMEQDolutegravir+Abacavir/Lamivudine50mg+600mg+300mg tab26.14500030783150011745002015Not specifiedNot specifiedNot specified
3Republic of PolandGovernmentViiv Healthcare UK LimitedTRIUMEQDolutegravir+Abacavir/Lamivudine50mg+600mg+300mg tab26.113500307834503523502015Not specifiedNot specifiedNot specified
4Republic of LatviaGovernmentViiv Healthcare UK LimitedTRIUMEQDolutegravir+Abacavir/Lamivudine50mg+600mg+300mg tab32.4843030974.521974.522015Not specifiedNot specifiedNot specified
5Republic of PolandGovernmentGlaxoSmithKlineTriumeqDolutegravir+Abacavir/Lamivudine50mg+600mg+300mg tab23.73312600030711.9942002990358Krajowe Centrum ds. AIDS2016YesYesNot specified
6Republic of PolandGovernmentGlaxoSmithKlineTriumeqDolutegravir+Abacavir/Lamivudine50mg+600mg+300mg tab23.02112600030690.6342002900646Krajowe Centrum ds. AIDS2016Not specifiedYesNot specified
7Republic of LatviaGovernmentViiv Healthcare UK LimitedTRIUMEQDolutegravir+Abacavir/Lamivudine50mg+600mg+300mg tab36.44327630301093.299211006920.06National Health Service (NHC)2016Not specifiedNot specifiedNot specified
8Republic of LithuaniaInsurance FundViiv Healthcare UK LimitedTRIUMEQDolutegravir+Abacavir/Lamivudine50mg+600mg+300mg tab33.421330301002.6411002.642016YesYesNot specified